NCT02535286 · Interventional trial
Study of Immunotherapy in Combination With Ublituximab and Umbralisib in Patients With Relapsed-refractory CLL or Richter's Transformation
Overall registry status Completed
Phase 1
Conditions Chronic Lymphocytic Leukemia, Richter Syndrome
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory